Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00379847 · ClinicalTrials.gov registry record · Phase 3

An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia

A Phase 3 study of Hyponatremia, sponsored by Cumberland Pharmaceuticals.

Completed
Registry status
Phase 3
Development phase
251
Enrollment target
20
Study locations

NCT00379847 is a Phase 3 study of Hyponatremia that has completed, run by Cumberland Pharmaceuticals. The registered enrollment target is 251 participants, roughly in line with the 254-participant average among 3 other Hyponatremia trials with a reported enrollment target. The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00379847, a Phase 3 study of Hyponatremia, has completed, sponsored by Cumberland Pharmaceuticals.

COMPLETED
Registry status
Phase 3
Development phase
251 participants
Enrollment target
20
Study locations

Study Summary

This study will investigate the application of a vasopressin antagonist in the treatment of hyponatremia most likely caused by inappropriate AVP secretion. The population studied will include patients with euvolemic or hypervolemic hyponatremia.

Conditions Studied

Hyponatremia

Interventions

  • DRUG conivaptan

Study Locations (20)

Other

  • - Afula
  • - Ashkelon
  • - Hadera
  • 2 Sites - Haifa
  • - Holon
  • 2 Sites - Jerusalem
  • - Nahariya
  • - Rehovot
  • 2 Sites - Safed
  • - Tel Aviv
  • - Ẕerifin
  • - Amanzimototi
  • - Bellville

Arizona

  • - Tuscon

Colorado

  • - Denver

District of Columbia

  • - Washington D.C.

Georgia

  • - Augusta

Michigan

  • - Petoskey

Ohio

  • - Cincinnati

South Carolina

  • - Columbia

Trial Details

FieldValue
Enrollment Target 251 participants
Start Date 2004-02
Est. Completion 2005-06
Phase Phase 3

Sponsor

Cumberland Pharmaceuticals

43 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00379847

The ClinicalTrials.gov registry entry for NCT00379847 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 254-participant average among 3 other Hyponatremia trials with a reported enrollment target. The listed sponsor is Cumberland Pharmaceuticals, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hyponatremia appearing as the primary indexed condition, and to 1 intervention - of which conivaptan is the first listed.

NCT00379847 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Other, Arizona, Colorado.

Frequently Asked Questions

What is clinical trial NCT00379847 about?

NCT00379847 is a clinical study titled "An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia". This study will investigate the application of a vasopressin antagonist in the treatment of hyponatremia most likely caused by inappropriate AVP secretion. The population studied will include patients with euvolemic or hypervolemic hyponatremia.

What is the current status of trial NCT00379847?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 251 participants. The study started on 2004-02. Estimated completion is 2005-06.

What conditions does trial NCT00379847 study?

This clinical trial studies the following conditions: Hyponatremia.

What interventions are being tested in trial NCT00379847?

The interventions under investigation include: conivaptan (DRUG).

Who is sponsoring clinical trial NCT00379847?

This trial is sponsored by Cumberland Pharmaceuticals, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00379847 being conducted?

This trial has 20 study locations across Arizona, Colorado, District of Columbia, Georgia, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hyponatremia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hyponatremia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.